Wells Fargo & Company »

Fennec Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Fennec Pharmaceuticals (FENC) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Fennec Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Fennec Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fennec Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $67k 6.0k 11.12
2023-12-31 $59k 5.2k 11.22
2023-09-30 $31k 4.1k 7.51
2023-06-30 $61k 7.0k 8.83
2021-09-30 $13k 1.4k 9.29
2021-06-30 $10k 1.4k 7.14
2021-03-31 $1.2M 186k 6.21
2020-12-31 $410k 55k 7.46
2020-09-30 $309k 51k 6.07
2020-06-30 $106k 13k 8.31
2020-03-31 $11k 1.8k 6.11
2019-06-30 $3.7k 1.1k 3.48
2019-03-31 $75k 15k 4.87
2018-12-31 $98k 15k 6.35
2018-09-30 $14k 1.8k 7.92
2018-06-30 $14k 1.4k 10.09